KLAC
56
4
MTCH
44
-2
CTAS
40
-5
MS
46
2
AN
35
6
USB
55
2
RF
44
3
SRE
35
3
GOOG
55
5
MDLZ
55
-10
SHW
50
-3
WFC
68
7
TXT
46
-2
CHD
51
-7
WY
44
2
REGN
36
-4
HPE
10
4
TSN
50
-2
MCD
57
-2
PBI
50
4
KLAC
56
4
MTCH
44
-2
CTAS
40
-5
MS
46
2
AN
35
6
USB
55
2
RF
44
3
SRE
35
3
GOOG
55
5
MDLZ
55
-10
SHW
50
-3
WFC
68
7
TXT
46
-2
CHD
51
-7
WY
44
2
REGN
36
-4
HPE
10
4
TSN
50
-2
MCD
57
-2
PBI
50
4
Financhill
Back

NetEase Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
68

NTES
NetEase

Last Price:
$103.82
Seasonality Move:
21.03%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.65
Seasonality Move:
6.73%
Buy
68
NetEase (NTES) is a Buy

Is NetEase a Buy, Sell or Hold?

  • The current NetEase [NTES] share price is $104.88. The Score for NTES is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • NTES is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTES Stock Price Chart

What is NetEase's stock price today?

  • The NetEase share price today is $104.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

NTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.71 Buy
Relative Strength Index (14 RSI): 57.17 Buy
Chaikin Money Flow: 964278 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.36 - 105.26) Buy
Bollinger Bands (100): (83.78 - 101.6) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

NTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.77 Buy
20-day SMA: 102.84 Buy
50-day SMA: 99.45 Buy
200-day SMA: 91.19 Buy
8-day EMA: 102.81 Buy
20-day EMA: 102.19 Buy
50-day EMA: 99.56 Buy
200-day EMA: 94.24 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

NetEase Earnings Growth & NTES Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.16 per share, an increase this year of $0.80 per share, and an increase next year of $0.53 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

NetEase Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):